4-Methyl-7-phenoxy-1H,2H,3H,4H,9H-cyclopenta[b]quinolin-9-one

Catalog No. :
ACCCRT846
CAS No. :
374918-94-2
Molecular Formula :
C19H17NO2
Molecular Weight :
291.35

IUPAC Name:4-methyl-7-phenoxy-1,2,3,4-tetrahydro-9H-cyclopenta[b]quinolin-9-one

4-Methyl-7-phenoxy-1H,2H,3H,4H,9H-cyclopenta[b]quinolin-9-one structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg95%$143.00Login to see priceInquiryInquiry
100mg95%$207.00Login to see priceInquiryInquiry
250mg95%$287.00Login to see priceInquiryInquiry
1g95%$676.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-Methyl-7-phenoxy-1H,2H,3H,4H,9H-cyclopenta[b]quinolin-9-one
IUPAC Name4-methyl-7-phenoxy-1,2,3,4-tetrahydro-9H-cyclopenta[b]quinolin-9-one
MDL No.MFCD02115681
Molecular FormulaC19H17NO2
Molecular Weight291.35
SMILESO=C1C(CCC2)=C2N(C)C3=C1C=C(OC4=CC=CC=C4)C=C3
InChI KeyIEPAVMQFOSNIHD-UHFFFAOYSA-N
Synonym4-methyl-7-phenoxy-1H,2H,3H,4H,9H-cyclopenta[b]quinolin-9-one;9H-Cyclopenta[b]quinolin-9-one, 1,2,3,4-tetrahydro-4-methyl-7-phenoxy-
CAS No.374918-94-2

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACCCRT846 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACCCRT846 route product structure diagram
    ACCCRT846374918-94-2
Inquiry

2. ACCCRT846 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACPBYR859 route compound structure diagram
    ACPBYR859100-67-4
  4. Then
  5. ACCCRT846 route product structure diagram
    ACCCRT846374918-94-2
Inquiry

Comments (0)